TERIPARATIDE- teriparatide injection, solution 
Apotex Corp.

----------

Medication Guide

Teriparatide Injection, USP

(ter” i par’ a tide)

for subcutaneous use

Read this Medication Guide before you start using teriparatide injection and each time you get a refill. There may be new information. Also, read the User Manual that comes with the teriparatide injection delivery device (pen) for information on how to use the device to inject your medicine the right way. This Medication Guide does not take the place of talking with your healthcare provider about your medical condition or your treatment.

What is the most important information I should know about teriparatide injection?

Possible bone cancer. During drug testing, the medicine in teriparatide injection caused some rats to develop a bone cancer called osteosarcoma.  Studies in people have not shown that teriparatide injection increases your chance of getting osteosarcoma. There is little information about the chance of getting osteosarcoma in patients using teriparatide injection beyond 2 years.

What is teriparatide injection?

Teriparatide injection is a prescription medicine used to:

It is not known if teriparatide injection is safe and effective in children.

Teriparatide injection should not be used in children and young adults whose bones are still growing.

Who should not use teriparatide injection?

Do not use teriparatide injection if you:

Symptoms of a serious allergic reaction of teriparatide injection may include swelling of the face, lips, tongue or throat that may cause difficulty in breathing or swallowing. Call your healthcare provider right away or get emergency medical help if you get any of these symptoms.

What should I tell my healthcare provider before using teriparatide injection?

Before you use teriparatide injection, tell your healthcare provider about all of your medical conditions, including if you:

Tell your healthcare provider about all the medicines you take including prescription and over-the-counter  medicines, vitamins, and herbal supplements.

Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

How should I use teriparatide injection?

If your healthcare provider recommends calcium and vitamin D supplements, you can take them at the same time you take teriparatide injection.

What are the possible side effects of teriparatide injection?

Teriparatide injection may cause serious side effects including:

The most common side effects of teriparatide injection include:

These are not all the possible side effects of teriparatide injection. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store teriparatide injection?

Keep teriparatide injection and all medicines out of the reach of children.

General information about the safe and effective use of teriparatide injection.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use teriparatide injection for a condition for which it was not prescribed. Do not give teriparatide injection to other people, even if they have the same symptoms that you have. It may harm them.

You can ask your pharmacist or healthcare provider for information about teriparatide injection that is written for health professionals.

What are the ingredients in teriparatide injection?

Active ingredient: teriparatide

Inactive ingredients: glacial acetic acid, sodium acetate (anhydrous), mannitol, metacresol, and water for injection. In addition, hydrochloric acid solution 10% and/or sodium hydroxide solution 10% may have been added to adjust the product to pH 4.

This Medication Guide has been approved by the U.S. Food and Drug Administration.

* All registered trademarks in this document are the property of their respective owners.

Medication Guide revised: January 2023

Marketed by: Apotex Corp. 2400 N. Commerce Parkway, Weston, FL 33326 U.S.A.

Revised: 1/2024
Apotex Corp.